Search research articles
Contact Us
Filters
Showing results (281-290 of 287) with videos related to
Page
of 29
Sort By:
You have reached the last page of results.
This site can display upto 287 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 13, 2023
[The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis]
S J Zhong, J J Gao, P Tang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
F Wang, X L Wei, F H Wang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
June 12, 2020
[The phenotypes and genotypes in 314 patients with isolated methylmalonic acidemia]
L L Kang, Y P Liu, M Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study
Y K Shi, L Wang, B H Han, et al.
Rhinology
|
October 30, 2023
Surgical treatment of nasopharyngeal cancer - a consensus recommendation from two Chinese associations
R You, Y P Liu, X Z Chen, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
December 11, 2019
[Consistency of ALK Ventana-D5F3 immunohistochemistry interpretation in lung adenocarcinoma among Chinese histopathologists]
L Li, L P Zhang, Y C Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
X Q Yan, M J Ye, Q Zou, et al.
Page
of 29
Search research articles
Search
Showing results (281-290 of 287) with videos related to
Sort By:
Page
of 29
You have reached the last page of results.
This site can display upto 287 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 13, 2023
[The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis]
S J Zhong, J J Gao, P Tang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
F Wang, X L Wei, F H Wang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
June 12, 2020
[The phenotypes and genotypes in 314 patients with isolated methylmalonic acidemia]
L L Kang, Y P Liu, M Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study
Y K Shi, L Wang, B H Han, et al.
Rhinology
|
October 30, 2023
Surgical treatment of nasopharyngeal cancer - a consensus recommendation from two Chinese associations
R You, Y P Liu, X Z Chen, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
December 11, 2019
[Consistency of ALK Ventana-D5F3 immunohistochemistry interpretation in lung adenocarcinoma among Chinese histopathologists]
L Li, L P Zhang, Y C Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
X Q Yan, M J Ye, Q Zou, et al.
Page
of 29